Status:
COMPLETED
PASCOE-Agil HOM-Injektopas in the Treatment of Rheumatic Disorders
Lead Sponsor:
Pascoe Pharmazeutische Praeparate GmbH
Conditions:
Rheumatic Diseases
Arthralgia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational study is to give an overview of the use of PASCOE-Agil HOM-Injektopas in a 2-4 week treatment of rheumatic disorders.
Detailed Description
The purpose of this observational study is to give an overview of the use of PASCOE-Agil HOM-Injektopas in a 2-4 week treatment of rheumatic disorders of different aetiology and localisation, displayi...
Eligibility Criteria
Inclusion
- Due to the design as an Observational Study no inclusion or exclusion criteria for therapy are named. The included patient group is described under "Cohort / Group".
- Observational Criteria (=inclusion criteria for documentation):
- Males and females
- At least 18 years old
- Rheumatic disease with accompanying symptoms, e.g. arthralgia, myalgia, lumbago etc.
- Exclusion criteria for documentation:
- younger than 18 years
- no Rheumatic disease with accompanying symptoms, e.g. arthralgia, myalgia, lumbago etc.
- no treatment with PASCOE-Agil HOM-Injektopas
Exclusion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
1389 Patients enrolled
Trial Details
Trial ID
NCT00922428
Start Date
January 1 2009
End Date
May 1 2009
Last Update
May 4 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.